🕵️ Oncology Institute, Inc. ($TOIIW)
SEC insider & ownership activity, last 12 months · CIK 1799191 · every row links its SEC filing
Over the last 12 months insiders sold $21.6M against $2.6M of open-market buying. M33 Growth I L.P. sold $20.7M in discretionary trades (Sep). Chernett Jorey added 5.2% → 10.2%. One red-flag 8-K in the window: Cyber incident (1.05), May 20, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $2.6M (15 lots) · 6 sellers, $21.6M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| M33 Growth I L.P. | 0 | – | 2 | $20.7M | Sep 4, 2025 |
| Chernett Jorey | 15 | $2.6M | 0 | – | Jul 21, 2026 |
| Mohit Kaushal | 0 | – | 2 | $335K | Apr 16, 2026 |
| Yale Podnos | 0 | – | 3 | $276K | Jul 14, 2026 |
| Mark Pacala | 0 | – | 3 | $200K | Nov 18, 2025 |
| Bradford Daniel Hively | 0 | – | 2 | $132K | Dec 15, 2025 |
| Carter Robert Ross | 0 | – | 1 | $879 | Jan 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Chernett Jorey | 10.2% | 13G | Mar 16, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Yale Podnos | $147K | Jul 14, 2026 | filing ↗ |
| Yale Podnos | $114K | Jun 8, 2026 | filing ↗ |
| Mohit Kaushal | $316K | Apr 14, 2026 | filing ↗ |
| Bradford Daniel Hively | $50K | Dec 15, 2025 | filing ↗ |
| Mark Pacala | $200K | Nov 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 1, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 1, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Cyber incident (1.05) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 13, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 23, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Nov 26, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 26, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 3, 2025 | filing ↗ |